Skip to main content

Infertility (IVF Patients)

2
Pipeline Programs
3
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Biocorp
BiocorpFrance - Issoire
1 program
1
hMG subcutaneous injectionPhase 3
Granata Bio
Granata BioMA - Duxbury
1 program
1
hMG subcutaneous injectionPhase 31 trial
Active Trials
NCT07216742Recruiting659Est. Nov 2028
Labcorp
LabcorpBURLINGTON, NC
1 program
Swim-upN/A1 trial
Active Trials
NCT07456397Recruiting500Est. Feb 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
Granata BiohMG subcutaneous injection
LabcorpSwim-up

Clinical Trials (2)

Total enrollment: 1,159 patients across 2 trials

NCT07216742Granata BiohMG subcutaneous injection

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

Start: Nov 2025Est. completion: Nov 2028659 patients
Phase 3Recruiting

Development of an AI Platform for the Analysis of Sperm and Prediction of Their Clinical Potential

Start: Mar 2026Est. completion: Feb 2028500 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
2 actively recruiting trials targeting 1,159 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.